Market Research Report Switzerland proton therapy centers,Global proton t | Page 3

Ken Research report titled “ Proton Therapy Market in Switzerland, Reimbursement Policy, Patients
Treated at Proton Facility & Forecast ” says effective growth of the proton therapy market of
Switzerland can be attributed to several other factors as well such as the increasing incidence of
varied tumors of brain and cancer patients in Switzerland, two advanced proton centers in
planning stage, technological advancements, and because of the growing health awareness
among masses of varied age-groups coupled with the extended spending of the consumer base.
However the bottom line is that it is still unknown as to whether the facilities will be ready on
schedule, provide treatment of a high enough standard, or be properly integrated with NHS care
and clinical research programs. And despite good intentions, availability for NHS patients will
depend on affordability and competing demand from paying customers.
The leading key companies facilitating the revenue as well as the growth of the proton therapy
market in Switzerland includes IBA, Varian Medical Systems and Elekta. The market is on the
peak of expanding with the planned future developments and growing technological progress.